| Predicate |
Object |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-92
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-24 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2818
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2827 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12 |
| filingDate |
2015-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2019-01-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
2019-01-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-106604742-B |
| titleOfInvention |
Anti-PD-L1 antibody and its use as a therapeutic and diagnostic agent |
| abstract |
The present invention provides antibodies that specifically bind to a programmed death-1 (PD1, Pdcd-1 or CD279) ligand (PD-L1) and inhibit PD-L1-mediated cell signaling and activity in immune cells. Antibodies of a set of amino acid residues required for antibody binding, and the use of these antibodies in the treatment or diagnosis of cancers, infectious diseases or other pathological conditions modulated by PD-L1-mediated functions. |
| priorityDate |
2014-07-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |